OBLN - Morgan Stanley reports 5.9% stake in Obalon Therapeutics September, 01 2020 08:39 AM Obalon Therapeutics Morgan Stanley reports 5.9% passive stake in Obalon Therapeutics (NASDAQ:OBLN) +8% representing 456K shares.More news on: Obalon Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...